FeaturesSignalPricingFounders
Log inGet started free
J&

Johnson & Johnson Development Corporation

Venture CapitalActive

Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.

New Brunswick, United StatesFounded 2005jnjinnovation.com/jjdc
153
Investments
6
Exits
AUM
3.9%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Johnson & Johnson Development Corporation.

Get started free

Investment Thesis & Strategy

Johnson & Johnson Development Corporation invests in various stages of biotech, consumer, and healthcare companies focused on patient health. They seek technology companies that align with Johnson & Johnson's strategic interests.

Investment Activity

Deals per year over the last 8 years

1
2014
2
2015
1
2016
0
2017
3
2018
2
2019
1
2020
2
2021

Portfolio Companies

Selected investments from their portfolio of 153 companies

T
Tessera Therapeutics
Biotech · Series B, 2021
Active
V
Vivani Medical
Biotech · Series A, 2021
Active
C
Cellarity
Biotech · Series B, 2020
Active
A
Achilles Therapeutics
Biotech · Series A, 2019
Active
X
Xilio Therapeutics
Biotech · Series A, 2019
Active
V
Vaxcyte
Biotech · Series A, 2018
Active
L
Lyndra Therapeutics
Biotech · Series B, 2018
Active
F
Foghorn Therapeutics
Biotech · Series A, 2018
Active
S
Surface Oncology
Biotech · Series A, 2016
Active
R
Revolution Medicines
Biotech · Series B, 2015
Active
H
Hookipa Pharma
Biotech · Series A, 2015
Active
K
Kodiak Sciences
Biotech · Series A, 2014
Active

Notable Exits

CompanyTypeYearValue / Acquirer
Momenta PharmaceuticalsAcquisition2020$6.5B
ActelionAcquisition2017$30B
Novira TherapeuticsAcquisition2015
Alios BioPharmaAcquisition2014$1.75B
Aragon PharmaceuticalsAcquisition2013$1B
Cougar BiotechnologyAcquisition2009$970M

Frequently Asked Questions

Johnson & Johnson Development Corporation focuses on Series A, Series B, Series C+ stage investments.

Related Investors